My Alzheimer's Journey
May 20, 2026
Hello Friends!
Happening down the street at Greg’s Alzheimer’s Research Report is a story about a small pharmaceutical company that is developing a promising adjunct drug to help manage cognitive impairments associated with mild-to-moderate Alzheimer’s disease.
The drug is known as Masitinib. They plan to start the Phase 3 clinical trial this year. All trial locations are in Europe (Spain and France). If you live in the United States, participating in a clinical trial in Europe seems like an awesome adventure.
Head over and learn more about AB Science and Masitinib. Don’t forget to hit the subscribe button!
I'm looking forward to updating you on my journey Friday.
